Impact of low fasting plasma glucose on mortality in the general population

Diab Vasc Dis Res. 2020 May-Jun;17(3):1479164120930599. doi: 10.1177/1479164120930599.

Abstract

Background: While the association between hypoglycaemia and poor outcomes in diabetes is well established, it is unclear whether such an association is generalizable to those without diabetes.

Methods: A total of 8497 participants free of cardiovascular disease and diabetes from the Third National Health and Nutrition Examination Survey were included. We examined the relationship between baseline low (<80 mg/dL) and high (⩾126 mg/dL) fasting plasma glucose compared to normal levels (80-99 mg/dL).

Results: Over a median follow-up of 14 years, 2101 deaths occurred, of which 570 were due to cardiovascular disease. In a model adjusted for sociodemographic and cardiovascular disease risk factors, individuals with low fasting plasma glucose were at increased risk of cardiovascular disease and all-cause mortality [hazard ratio = 1.79 (95% confidence interval = 1.04-3.08) and hazard ratio = 1.35 (95% confidence interval = 1.02-1.78), respectively], compared to those with normal fasting plasma glucose. These associations were stronger among men than women for both cardiovascular disease mortality and all-cause mortality.

Conclusion: Low fasting plasma glucose in individuals without diabetes is a risk factor for cardiovascular disease and all-cause mortality, especially in men.

Keywords: Low fasting plasma glucose; Third National Health and Nutrition Examination Survey; cardiovascular mortality; hypoglycaemia.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Blood Glucose / analysis*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / mortality*
  • Cause of Death
  • Fasting / blood*
  • Female
  • Humans
  • Hypoglycemia / blood*
  • Hypoglycemia / diagnosis
  • Hypoglycemia / mortality*
  • Male
  • Middle Aged
  • Nutrition Surveys
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Time Factors
  • United States / epidemiology
  • Young Adult

Substances

  • Biomarkers
  • Blood Glucose